VX-264

E1188110 UNEXPLORED

VX-264 is an investigational therapy being developed by Vertex Pharmaceuticals, likely targeting a serious disease area such as cystic fibrosis or another genetic condition within the company’s clinical pipeline.

All labels observed (1)

Label Occurrences
VX-264 canonical 1

How this entity was disambiguated

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.